This report contains market size and forecasts of Respiratory Inhalers in Global, including the following market information:
Global Respiratory Inhalers Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Respiratory Inhalers market was valued at 29640 million in 2020 and is projected to reach US$ 31200 million by 2027, at a CAGR of 1.3% during the forecast period.
Publisher has surveyed the Respiratory Inhalers companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Respiratory Inhalers Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Respiratory Inhalers Market Segment Percentages, By Type, 2020 (%)
Dry Powder Inhaler
Metered Dose Inhaler
Others
China Respiratory Inhalers Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Respiratory Inhalers Market Segment Percentages, By Application, 2020 (%)
Asthma
COPD
Other
Global Respiratory Inhalers Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Respiratory Inhalers Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Respiratory Inhalers Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Respiratory Inhalers Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Adherium limited
AstraZeneca
Boehringer Ingelheim GmbH
Chiesi Farmaceutici S.p.A.
GSK plc.
Propeller Health
Teva Pharmaceutical Industries Ltd.
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Respiratory Inhalers Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Respiratory Inhalers Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Respiratory Inhalers Overall Market Size
2.1 Global Respiratory Inhalers Market Size: 2021 VS 2027
2.2 Global Respiratory Inhalers Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Respiratory Inhalers Players in Global Market
3.2 Top Global Respiratory Inhalers Companies Ranked by Revenue
3.3 Global Respiratory Inhalers Revenue by Companies
3.4 Top 3 and Top 5 Respiratory Inhalers Companies in Global Market, by Revenue in 2020
3.5 Global Companies Respiratory Inhalers Product Type
3.6 Tier 1, Tier 2 and Tier 3 Respiratory Inhalers Players in Global Market
3.6.1 List of Global Tier 1 Respiratory Inhalers Companies
3.6.2 List of Global Tier 2 and Tier 3 Respiratory Inhalers Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Respiratory Inhalers Market Size Markets, 2021 & 2027
4.1.2 Dry Powder Inhaler
4.1.3 Metered Dose Inhaler
4.1.4 Others
4.2 By Type - Global Respiratory Inhalers Revenue & Forecasts
4.2.1 By Type - Global Respiratory Inhalers Revenue, 2016-2021
4.2.2 By Type - Global Respiratory Inhalers Revenue, 2022-2027
4.2.3 By Type - Global Respiratory Inhalers Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Respiratory Inhalers Market Size, 2021 & 2027
5.1.2 Asthma
5.1.3 COPD
5.1.4 Other
5.2 By Application - Global Respiratory Inhalers Revenue & Forecasts
5.2.1 By Application - Global Respiratory Inhalers Revenue, 2016-2021
5.2.2 By Application - Global Respiratory Inhalers Revenue, 2022-2027
5.2.3 By Application - Global Respiratory Inhalers Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Respiratory Inhalers Market Size, 2021 & 2027
6.2 By Region - Global Respiratory Inhalers Revenue & Forecasts
6.2.1 By Region - Global Respiratory Inhalers Revenue, 2016-2021
6.2.2 By Region - Global Respiratory Inhalers Revenue, 2022-2027
6.2.3 By Region - Global Respiratory Inhalers Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Respiratory Inhalers Revenue, 2016-2027
6.3.2 US Respiratory Inhalers Market Size, 2016-2027
6.3.3 Canada Respiratory Inhalers Market Size, 2016-2027
6.3.4 Mexico Respiratory Inhalers Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Respiratory Inhalers Revenue, 2016-2027
6.4.2 Germany Respiratory Inhalers Market Size, 2016-2027
6.4.3 France Respiratory Inhalers Market Size, 2016-2027
6.4.4 U.K. Respiratory Inhalers Market Size, 2016-2027
6.4.5 Italy Respiratory Inhalers Market Size, 2016-2027
6.4.6 Russia Respiratory Inhalers Market Size, 2016-2027
6.4.7 Nordic Countries Respiratory Inhalers Market Size, 2016-2027
6.4.8 Benelux Respiratory Inhalers Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Respiratory Inhalers Revenue, 2016-2027
6.5.2 China Respiratory Inhalers Market Size, 2016-2027
6.5.3 Japan Respiratory Inhalers Market Size, 2016-2027
6.5.4 South Korea Respiratory Inhalers Market Size, 2016-2027
6.5.5 Southeast Asia Respiratory Inhalers Market Size, 2016-2027
6.5.6 India Respiratory Inhalers Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Respiratory Inhalers Revenue, 2016-2027
6.6.2 Brazil Respiratory Inhalers Market Size, 2016-2027
6.6.3 Argentina Respiratory Inhalers Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Respiratory Inhalers Revenue, 2016-2027
6.7.2 Turkey Respiratory Inhalers Market Size, 2016-2027
6.7.3 Israel Respiratory Inhalers Market Size, 2016-2027
6.7.4 Saudi Arabia Respiratory Inhalers Market Size, 2016-2027
6.7.5 UAE Respiratory Inhalers Market Size, 2016-2027
7 Players Profiles
7.1 Adherium limited
7.1.1 Adherium limited Corporate Summary
7.1.2 Adherium limited Business Overview
7.1.3 Adherium limited Respiratory Inhalers Major Product Offerings
7.1.4 Adherium limited Respiratory Inhalers Revenue in Global (2016-2021)
7.1.5 Adherium limited Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Respiratory Inhalers Major Product Offerings
7.2.4 AstraZeneca Respiratory Inhalers Revenue in Global (2016-2021)
7.2.5 AstraZeneca Key News
7.3 Boehringer Ingelheim GmbH
7.3.1 Boehringer Ingelheim GmbH Corporate Summary
7.3.2 Boehringer Ingelheim GmbH Business Overview
7.3.3 Boehringer Ingelheim GmbH Respiratory Inhalers Major Product Offerings
7.3.4 Boehringer Ingelheim GmbH Respiratory Inhalers Revenue in Global (2016-2021)
7.3.5 Boehringer Ingelheim GmbH Key News
7.4 Chiesi Farmaceutici S.p.A.
7.4.1 Chiesi Farmaceutici S.p.A. Corporate Summary
7.4.2 Chiesi Farmaceutici S.p.A. Business Overview
7.4.3 Chiesi Farmaceutici S.p.A. Respiratory Inhalers Major Product Offerings
7.4.4 Chiesi Farmaceutici S.p.A. Respiratory Inhalers Revenue in Global (2016-2021)
7.4.5 Chiesi Farmaceutici S.p.A. Key News
7.5 GSK plc.
7.5.1 GSK plc. Corporate Summary
7.5.2 GSK plc. Business Overview
7.5.3 GSK plc. Respiratory Inhalers Major Product Offerings
7.5.4 GSK plc. Respiratory Inhalers Revenue in Global (2016-2021)
7.5.5 GSK plc. Key News
7.6 Propeller Health
7.6.1 Propeller Health Corporate Summary
7.6.2 Propeller Health Business Overview
7.6.3 Propeller Health Respiratory Inhalers Major Product Offerings
7.6.4 Propeller Health Respiratory Inhalers Revenue in Global (2016-2021)
7.6.5 Propeller Health Key News
7.7 Teva Pharmaceutical Industries Ltd.
7.7.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
7.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.7.3 Teva Pharmaceutical Industries Ltd. Respiratory Inhalers Major Product Offerings
7.4.4 Teva Pharmaceutical Industries Ltd. Respiratory Inhalers Revenue in Global (2016-2021)
7.7.5 Teva Pharmaceutical Industries Ltd. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Respiratory Inhalers Market Opportunities & Trends in Global Market
Table 2. Respiratory Inhalers Market Drivers in Global Market
Table 3. Respiratory Inhalers Market Restraints in Global Market
Table 4. Key Players of Respiratory Inhalers in Global Market
Table 5. Top Respiratory Inhalers Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Respiratory Inhalers Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Respiratory Inhalers Revenue Share by Companies, 2016-2021
Table 8. Global Companies Respiratory Inhalers Product Type
Table 9. List of Global Tier 1 Respiratory Inhalers Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Respiratory Inhalers Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Respiratory Inhalers Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Respiratory Inhalers Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Respiratory Inhalers Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Respiratory Inhalers Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Respiratory Inhalers Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Respiratory Inhalers Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Respiratory Inhalers Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Respiratory Inhalers Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Respiratory Inhalers Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Respiratory Inhalers Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Respiratory Inhalers Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Respiratory Inhalers Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Respiratory Inhalers Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Respiratory Inhalers Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Respiratory Inhalers Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Respiratory Inhalers Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Respiratory Inhalers Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Respiratory Inhalers Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Respiratory Inhalers Revenue, (US$, Mn), 2022-2027
Table 30. Adherium limited Corporate Summary
Table 31. Adherium limited Respiratory Inhalers Product Offerings
Table 32. Adherium limited Respiratory Inhalers Revenue (US$, Mn), (2016-2021)
Table 33. AstraZeneca Corporate Summary
Table 34. AstraZeneca Respiratory Inhalers Product Offerings
Table 35. AstraZeneca Respiratory Inhalers Revenue (US$, Mn), (2016-2021)
Table 36. Boehringer Ingelheim GmbH Corporate Summary
Table 37. Boehringer Ingelheim GmbH Respiratory Inhalers Product Offerings
Table 38. Boehringer Ingelheim GmbH Respiratory Inhalers Revenue (US$, Mn), (2016-2021)
Table 39. Chiesi Farmaceutici S.p.A. Corporate Summary
Table 40. Chiesi Farmaceutici S.p.A. Respiratory Inhalers Product Offerings
Table 41. Chiesi Farmaceutici S.p.A. Respiratory Inhalers Revenue (US$, Mn), (2016-2021)
Table 42. GSK plc. Corporate Summary
Table 43. GSK plc. Respiratory Inhalers Product Offerings
Table 44. GSK plc. Respiratory Inhalers Revenue (US$, Mn), (2016-2021)
Table 45. Propeller Health Corporate Summary
Table 46. Propeller Health Respiratory Inhalers Product Offerings
Table 47. Propeller Health Respiratory Inhalers Revenue (US$, Mn), (2016-2021)
Table 48. Teva Pharmaceutical Industries Ltd. Corporate Summary
Table 49. Teva Pharmaceutical Industries Ltd. Respiratory Inhalers Product Offerings
Table 50. Teva Pharmaceutical Industries Ltd. Respiratory Inhalers Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Respiratory Inhalers Segment by Type
Figure 2. Respiratory Inhalers Segment by Application
Figure 3. Global Respiratory Inhalers Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Respiratory Inhalers Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Respiratory Inhalers Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Respiratory Inhalers Revenue in 2020
Figure 8. By Type - Global Respiratory Inhalers Revenue Market Share, 2016-2027
Figure 9. By Application - Global Respiratory Inhalers Revenue Market Share, 2016-2027
Figure 10. By Region - Global Respiratory Inhalers Revenue Market Share, 2016-2027
Figure 11. By Country - North America Respiratory Inhalers Revenue Market Share, 2016-2027
Figure 12. US Respiratory Inhalers Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Respiratory Inhalers Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Respiratory Inhalers Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Respiratory Inhalers Revenue Market Share, 2016-2027
Figure 16. Germany Respiratory Inhalers Revenue, (US$, Mn), 2016-2027
Figure 17. France Respiratory Inhalers Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Respiratory Inhalers Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Respiratory Inhalers Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Respiratory Inhalers Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Respiratory Inhalers Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Respiratory Inhalers Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Respiratory Inhalers Revenue Market Share, 2016-2027
Figure 24. China Respiratory Inhalers Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Respiratory Inhalers Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Respiratory Inhalers Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Respiratory Inhalers Revenue, (US$, Mn), 2016-2027
Figure 28. India Respiratory Inhalers Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Respiratory Inhalers Revenue Market Share, 2016-2027
Figure 30. Brazil Respiratory Inhalers Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Respiratory Inhalers Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Respiratory Inhalers Revenue Market Share, 2016-2027
Figure 33. Turkey Respiratory Inhalers Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Respiratory Inhalers Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Respiratory Inhalers Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Respiratory Inhalers Revenue, (US$, Mn), 2016-2027
Figure 37. Adherium limited Respiratory Inhalers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. AstraZeneca Respiratory Inhalers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Boehringer Ingelheim GmbH Respiratory Inhalers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Chiesi Farmaceutici S.p.A. Respiratory Inhalers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. GSK plc. Respiratory Inhalers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Propeller Health Respiratory Inhalers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Teva Pharmaceutical Industries Ltd. Respiratory Inhalers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Adherium limited
AstraZeneca
Boehringer Ingelheim GmbH
Chiesi Farmaceutici S.p.A.
GSK plc.
Propeller Health
Teva Pharmaceutical Industries Ltd.